Drug History: NOVOLIN N

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Label and Approval History

Drug Name:	NOVOLIN N
FDA Application No:	(NDA) 019959
Active Ingredient(s):	INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
Company:	NOVO NORDISK INC

Label History

View the label approved on April 17, 2003 for NOVOLIN N, (NDA) 019959

To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.

Approval History

Action Date	Supplement Number	Approval Type	Letters, Reviews, Labels, Patient Package Insert
6/19/2002	039	Manufacturing Change or Addition
1/10/2002	038	Control Supplement
12/19/2001	036	Package Change	Label
4/15/2002	035	Package Change	Letter Label
4/11/2002	034	Package Change	Letter Label
1/9/2001	033	Control Supplement
12/13/2000	032	Control Supplement
3/11/2002	031	Labeling Revision	Letter Label
12/17/2001	030	Labeling Revision
2/21/2001	029	Control Supplement
6/15/2000	028	Labeling Revision
4/10/2000	027	Control Supplement
3/16/2000	026	Package Change
10/18/1999	025	Manufacturing Change or Addition
7/24/1998	024	Control Supplement
8/4/1997	023	Control Supplement
6/20/1997	022	Package Change
4/16/1997	021	Labeling Revision	Review
1/2/1997	020	Control Supplement
4/10/1997	019	Labeling Revision
8/8/1996	018	Manufacturing Change or Addition
1/28/1997	017	Control Supplement
5/22/1995	016	Control Supplement
1/4/1994	015	Labeling Revision
1/3/1994	014	Labeling Revision
6/23/1994	013	Package Change
6/23/1994	012	Control Supplement
6/16/1994	011	Control Supplement
5/31/1994	010	Control Supplement
5/23/1994	009	Control Supplement
4/26/1994	008	Control Supplement
1/7/1994	007	Labeling Revision
3/26/1993	006	Labeling Revision
3/26/1993	004	Control Supplement
3/13/1992	002	Control Supplement
10/7/1991	001	Control Supplement
7/1/1991	000	Approval

Therapeutic Equivalents